Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5852253

Cl.Cl.Cl.O.O.O.O.O.O.[La]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.33
CA5A P35218 1/20 0.33
CA5B Q9Y2D0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116003373-B Method for preparing trans-1, 2-dimethyl ethylene carbonate by catalytic isomerization 上海如鲲新材料股份有限公司 2023-06-13 CN claimed
CN-106750936-B Rare earth-iron-boron and expansion type flame retardant cooperative flame retardant PP composite material and preparation method thereof 浙江大学宁波理工学院 2019-11-19 CN claimed
CN-109810272-A A kind of oxidation nanometer cellulose two-dimensional metallic organic backbone composite fluorescent film and preparation method thereof 陕西科技大学 2019-05-28 CN claimed
CN-109772278-A A kind of synchronous fixed arsenic, antimony, adsorbed film of vanadium ion and preparation method thereof 南京大学 2019-05-21 CN claimed
CN-109550501-A A kind of preparation method and applications of nitrobenzene liquid-phase hydrogenatin catalyst in aniline 万华化学集团股份有限公司 2019-04-02 CN claimed
CN-108753210-A A kind of preparation method of sprayable wallpaper binder 安徽索亚装饰材料有限公司 2018-11-06 CN claimed
CN-108097202-A A kind of preparation method of the sewage-treating agent of water depth dephosphorization 芜湖皖江知识产权运营中心有限公司 2018-06-01 CN claimed
CN-107603599-A A kind of Lanthanide complex blue emitting material and synthetic method 桂林理工大学 2018-01-19 CN claimed
CN-106750936-A Rare earth-iron-boron and expansion type flame retardant cooperative flame retardant PP composite material and preparation method thereof 浙江大学宁波理工学院 2017-05-31 CN claimed
CN-106430947-A Preparation method of quartz glass and quartz glass 中国建筑材料科学研究总院 2017-02-22 CN claimed
CN-106380072-A Preparation method for quartz glass and quartz glass 中国建筑材料科学研究总院 2017-02-08 CN claimed
CN-106365438-A Quartz glass and preparation method thereof 中国建筑材料科学研究总院 2017-02-01 CN claimed
CN-102344375-A Preparation and synthesis method for 3-aminomethylbenzylamine hydrochloride MEI LUO 2012-02-08 CN claimed
CN-117482982-B Gallium or indium doped S-1 molecular sieve encapsulated metal catalyst and preparation method and application thereof 中触媒新材料股份有限公司 2026-02-27 CN disclosed
CN-119409564-A Rare earth complex, rare earth composition, and preparation method and application thereof 中国科学院赣江创新研究院 2025-02-11 CN disclosed
CN-114591548-B Nuclear-grade oil-resistant asbestos-free fiber sealing material and preparation method thereof 浙江国泰萧星密封材料股份有限公司 2024-03-26 CN disclosed
US-7122643-B2 Cytostatic lanthanum compounds FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH (DE) 2006-10-17 US disclosed
CN-1739852-A Catalyst for preparing p-cyclodexanone dioxide UNIV SICHUAN (CN) 2006-03-01 CN disclosed
US-20040176346-A1 Cytostatic lanthanum compounds FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH 2004-09-09 US disclosed
CN-1481278-A Process of preparing fluid rare earth alkoxylation catalyst ���ʿ����о����޹�˾ 2004-03-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176346-A1 Cytostatic lanthanum compounds NCL, LMNB1, LYAR CA4 286/4885CA5A 138/4885CA5B 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.